Epsilon Healthcare Ltd
Company Profile
Business description
Epsilon Healthcare Ltd is a diversified healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, (the Southport Facility) in Southport, Australia and the Tetra Health clinic group. It is engaged in two segments: Contract Development and Manufacturing activities; and Telehealth medical practice services. Contract Development and Manufacturing activities as a CDMO for Australian domiciled and international clients in the area of Active Pharmaceutical Ingredient (API) manufacture and finished formulation production. Key revenue is generated from Contract Development and Manufacturing.
Contact
1 Jamison Street
Level 1
SydneyNSW2000
AUST: +61 288393000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
stocks
Westpac earnings: Tech overhaul is costly but not hurting lending and deposit growth
stocks
Berkshire Hathaway earnings: Cash balances hit $358 billion on mostly solid results across the firm
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,138.20 | 35.80 | -0.39% |
| CAC 40 | 8,109.79 | 11.28 | -0.14% |
| DAX 40 | 24,132.41 | 174.11 | 0.73% |
| Dow JONES (US) | 47,336.68 | 226.19 | -0.48% |
| FTSE 100 | 9,701.37 | 15.88 | -0.16% |
| HKSE | 26,158.36 | 251.71 | 0.97% |
| NASDAQ | 23,834.72 | 109.77 | 0.46% |
| Nikkei 225 | 52,389.43 | 21.91 | -0.04% |
| NZX 50 Index | 13,617.81 | 61.51 | 0.45% |
| S&P 500 | 6,851.97 | 11.77 | 0.17% |
| S&P/ASX 200 | 8,850.20 | 32.50 | -0.37% |
| SSE Composite Index | 3,976.48 | 0.04 | -0.00% |